These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 26056734)
1. The association of serum-free light-chain levels with markers of renal function. Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734 [TBL] [Abstract][Full Text] [Related]
2. Glomerular filtration rate as a determinant of free light chains in renal transplantation. Bargnoux AS; Simon N; Garrigue V; Dupuy AM; Badiou S; Mourad G; Cristol JP Clin Biochem; 2013 Nov; 46(16-17):1764-6. PubMed ID: 24028899 [TBL] [Abstract][Full Text] [Related]
3. N Latex FLC serum free light-chain assays in patients with renal impairment. Jacobs JF; Hoedemakers RM; Teunissen E; Te Velthuis H Clin Chem Lab Med; 2014 Jun; 52(6):853-9. PubMed ID: 24406282 [TBL] [Abstract][Full Text] [Related]
4. The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease. Molina-Andújar A; Robles P; Cibeira MT; Montagud-Marrahi E; Guillen E; Xipell M; Blasco M; Poch E; Rosiñol L; Bladé J; Quintana LF BMC Nephrol; 2020 Mar; 21(1):111. PubMed ID: 32234026 [TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma. Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850 [TBL] [Abstract][Full Text] [Related]
6. Hemodiafiltration improves free light chain removal and normalizes κ/λ ratio in hemodialysis patients. Bourguignon C; Chenine L; Bargnoux AS; Leray-Moragues H; Canaud B; Cristol JP; Morena M J Nephrol; 2016 Apr; 29(2):251-257. PubMed ID: 26022721 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Impact of Renal Failure on Correlation and Concordance Between 2 Free Light Chain Assays. Moreau C; Autier B; Cavey T; Rouger E; Norwood J; Bendavid C; Escoffre M; Sébillot M; Decaux O Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):693-704. PubMed ID: 27618362 [TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease. Hutchison CA; Harding S; Hewins P; Mead GP; Townsend J; Bradwell AR; Cockwell P Clin J Am Soc Nephrol; 2008 Nov; 3(6):1684-90. PubMed ID: 18945993 [TBL] [Abstract][Full Text] [Related]
9. Robust Reference Intervals for Serum Kappa and Lambda Free Light Chains from a Multi Centre Study Population from Hyderabad, India: Myeloma Diagnostic Implications. Mohammed N; Chandran PA; Kandregula M; Mattaparthi RD; Gundeti S; Volturi J; Darapuneni R; Raju SB; Dattatreya PS Asian Pac J Cancer Prev; 2016; 17(5):2605-10. PubMed ID: 27268638 [TBL] [Abstract][Full Text] [Related]
10. Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome. Wang C; Su W; Zhang W; Di Q; Duan MH; Ji W; Cao XX; Zhou DB; Li J Ann Hematol; 2014 Jul; 93(7):1201-6. PubMed ID: 24482101 [TBL] [Abstract][Full Text] [Related]
11. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof]. Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880 [TBL] [Abstract][Full Text] [Related]
12. Effects of Long-Term Storage on Serum Free Light Chain Stability. Hörber S; Klein R; Peter A Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238 [TBL] [Abstract][Full Text] [Related]
13. Serum free light chain analysis: persisting limitations with new kids on the block. Van Hoovels L; Vercammen M; Nevejan L; Cornette M; Briers PJ; Deeren D; Van Droogenbroeck J; Fostier K; De Smet D Clin Chem Lab Med; 2022 Aug; 60(9):1440-1448. PubMed ID: 35781357 [TBL] [Abstract][Full Text] [Related]
15. [Clinical Significance of Serum Free Light Chain in Monoclonal Gammopathy]. Lu H; Zhang W Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):155-158. PubMed ID: 38387914 [TBL] [Abstract][Full Text] [Related]
16. Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies. Böer K; Deufel T Clin Chem Lab Med; 2009; 47(9):1109-15. PubMed ID: 19728853 [TBL] [Abstract][Full Text] [Related]
17. Assessment of serum free light chain levels in healthy adults immediately after marathon running. Campbell JP; Eijsvogels TM; Wang Y; Hopman MT; Jacobs JF Clin Chem Lab Med; 2016 Mar; 54(3):459-65. PubMed ID: 26351935 [TBL] [Abstract][Full Text] [Related]
18. [Clinical Significance of Serum Free Light Chain and Its κ/λ Ratio in Patients with Multiple Myeloma]. Zhao D; Jiang JQ; Lin L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1173-1178. PubMed ID: 31418375 [TBL] [Abstract][Full Text] [Related]
19. Comparison between on-line high-efficiency hemodiafiltration and conventional high-flux hemodialysis for polyclonal free light chain removal. Lamy T; Henri P; Lobbedez T; Comby E; Ryckelynck JP; Ficheux M Blood Purif; 2014; 37(2):93-8. PubMed ID: 24603634 [TBL] [Abstract][Full Text] [Related]
20. [The prognostic value of baseline serum free light chain in cardiac amyloidosis]. Zhao L; Tian Z; Fang Q Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):186-90. PubMed ID: 26926369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]